Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Soleno Therapeutics Inc.

    NASDAQ: SLNO · Real-Time Price · USD
    78.20
    -0.95 (-1.20%)
    At close: Jun 16, 2025, 3:59 PM
    77.89
    -0.40%
    Pre-market: Jun 17, 2025, 05:03 AM EDT

    Soleno Therapeutics Statistics

    Share Statistics

    Soleno Therapeutics has 50.39M shares outstanding. The number of shares has increased by 25.94% in one year.

    Shares Outstanding

    n/a
    		 50.39M

    Shares Change (YoY)

    n/a
    		 25.94%

    Shares Change (QoQ)

    n/a
    		 6.35%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 41.75M

    Failed to Deliver (FTD) Shares

    n/a
    		 229

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 3.99M, so 7.91% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.99M

    Short % of Shares Out

    n/a
    		 7.91%

    Short % of Float

    n/a
    		 9.11%

    Short Ratio (days to cover)

    n/a
    		 6.43

    Valuation Ratios

    The PE ratio is -10.27 and the forward PE ratio is 98.96. Soleno Therapeutics's PEG ratio is -0.12.

    PE Ratio

    n/a
    		 -10.27

    Forward PE

    n/a
    		 98.96

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 7.37

    P/FCF Ratio

    n/a
    		 -26.05

    PEG Ratio

    n/a
    		 -0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Soleno Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.68, with a Debt / Equity ratio of 0.22.

    Current Ratio

    n/a
    		 15.68

    Quick Ratio

    n/a
    		 15.68

    Debt / Equity

    n/a
    		 0.22

    Debt / EBITDA

    n/a
    		 -0.3

    Debt / FCF

    n/a
    		 -0.76

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,529,130.43

    Employee Count

    n/a
    		 115

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 84.04% in the last 52 weeks. The beta is -2.67, so Soleno Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -2.67

    52-Week Price Change

    n/a
    		 84.04%

    50-Day Moving Average

    n/a
    		 73.74

    200-Day Moving Average

    n/a
    		 56.41

    Relative Strength Index (RSI)

    n/a
    		 56.59

    Average Volume (20 Days)

    n/a
    		 1,307,773

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -184.43M

    Net Income

    n/a
    		 -175.85M

    EBITDA

    n/a
    		 -173.63M

    EBIT

    n/a
    		 -175.62M

    Earnings Per Share (EPS)

    n/a
    		 -4.38
    Full Income Statement

    Balance Sheet

    The company has 87.93M in cash and 52.83M in debt, giving a net cash position of 35.1M.

    Cash & Cash Equivalents

    n/a
    		 87.93M

    Total Debt

    n/a
    		 52.83M

    Net Cash

    n/a
    		 35.1M

    Retained Earnings

    n/a
    		 -452.26M

    Total Assets

    n/a
    		 318.09M

    Working Capital

    n/a
    		 293.18M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -69.1M and capital expenditures -218K, giving a free cash flow of -69.31M.

    Operating Cash Flow

    n/a
    		 -69.1M

    Capital Expenditures

    n/a
    		 -218K

    Free Cash Flow

    n/a
    		 -69.31M

    FCF Per Share

    n/a
    		 -1.73
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SLNO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SLNO is $105, which is 34.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $105

    Price Target Difference

    n/a
    		 34.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 26, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Aug 26, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 23.92

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist